Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for Marijuana Withdrawal
NCT00142870Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Mar 2005
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cannabis withdrawal and cannabis use disorder (CUD) comparing Bupropion with Placebo (2 arms). Primary endpoint: Withdrawal severity. Started Mar 2005; status: completed.
02
Drugs
bupropion
03
Conditions
cannabis withdrawalcannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT00142870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00142870.